Soluble molecule profiling and network analysis of primary Sjögren's Syndrome patient serumJ Tarn, Wan‐Fai Ng, A Natasari et al.|BMC Musculoskeletal Disorders|2013Cited by 35
Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritisRyan Malcolm Hum, Ann Brownfield, John D. Isaacs et al.|Lara D. Veeken|2022Cited by 8